Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver

被引:98
|
作者
Washington, K
Wright, K
Shyr, Y
Hunter, EB
Olson, S
Raiford, DS
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA
关键词
nonalcoholic steatohepatitis; fibrosis; steatosis; hepatic stellate cell;
D O I
10.1053/hupa.2000.8440
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Factors associated with the development of fibrosis in nonalcoholic steatohepatitis (NASH) are largely unknown, although an association with increased hepatic iron has been suggested. Hepatic stellate cells are the principal collagen-producing cells in many liver diseases and when activated express alpha-smooth muscle actin (alpha-SMA). Hepatic stellate cell activation and association with fibrosis, necroinflammatory activity steatosis, and stainable iron in 60 cases of NASH and 16 cases of steatosis were evaluated. All 76 patients were obese or had other risk factors for NASH. All biopsy specimens were stained for alpha-smooth muscle actin to evaluate the pattern of hepatic stellate cell activation and were evaluated for inflammatory activity (0 to 3), fibrosis (0 to 4), and stainable iron stores (0 to 4). The zonal location of activated stellate cells was recorded, and the degree of activation was graded as high-grade or low-grade based on the percentage of lobular alpha-SMA+ cells. Activated stellate cells were identified in the hepatic lobule in 74 of 76 biopsy specimens and graded as low-grade in 26 and high-grade in 48. Zone 3 was involved in 72 of 74 positive cases, and in 33 cases, the activated stellate cells were preferentially located in zone 3, The degree of stellate cell activation correlated with fibrosis but not with inflammatory activity, severity of steatosis, or stainable iron. In most cases, the degree of stellate cell activation paralleled the degree of hepatic fibrosis, but in 25 cases, the degree of hepatic stellate cell activation was greater than expected, raising the question of whether such patients are at risk for disease progression. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:822 / 828
页数:7
相关论文
共 50 条
  • [21] Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Brown, Gregory Thomas
    Kleiner, David E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1080 - 1086
  • [22] Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Fukusato, Toshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15539 - 15548
  • [23] Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic steatohepatitis
    Manne, Vignan
    Handa, Priya
    Kowdley, Kris V.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 23 - +
  • [24] Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Toshio Fukusato
    World Journal of Gastroenterology, 2014, (42) : 15539 - 15548
  • [25] Metformin for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Farah, Samira
    Thu Nguyen
    Kelsberg, Gary
    Safranek, Sarah
    AMERICAN FAMILY PHYSICIAN, 2019, 99 (04) : 262 - 263
  • [26] Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan
    Okanoue, Takeshi
    Umemura, Atsushi
    Yasui, Kohichiroh
    Itoh, Yoshito
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 153 - 162
  • [27] Effect of pentoxifylline on clinical, biochemical and metabolic parameters, hepatic necroinflammation, fibrosis and stellate cell activation in patients with nonalcoholic steatohepatitis
    Singh, Deepak K.
    Sakhuja, Puja
    Rastogi, Archana
    Kumar, Ajay
    Gondal, Ranjana
    Sarin, Shiv K.
    HEPATOLOGY, 2007, 46 (04) : 734A - 734A
  • [28] Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease
    Feldstein, AE
    Papouchado, BG
    Angulo, P
    Sanderson, S
    Adams, L
    Gores, GJ
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (04) : 384 - 389
  • [29] Nonalcoholic fatty liver disease (NAFLD) in morbid obese patients: Clinical and laboratory features and immunohistochemical investigation of hepatic stellate cell activation
    Riguelme, A
    Boza, C
    Gomez, C
    Duarte, I
    Guzman, S
    Arrese, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 258 - 259
  • [30] Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease
    Ezquerro, Silvia
    Tuero, Carlota
    Becerril, Sara
    Valenti, Victor
    Moncada, Rafael
    Landecho, Manuel F.
    Catalan, Victoria
    Gomez-Ambrosi, Javier
    Mocha, Fatima
    Silva, Camilo
    Hanley, Karen Piper
    Escalada, Javier
    Fruhbeck, Gema
    Rodriguez, Amaia
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2023, 188 (07) : 564 - 577